|
|
Volumn 349, Issue , 2014, Pages
|
|
Risks in the balance: The statins row
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
CARDIOVASCULAR RISK;
DOCTOR PATIENT RELATION;
DRUG USE;
EVIDENCE BASED MEDICINE;
HUMAN;
MEDICAL LITERATURE;
MEDICAL SOCIETY;
PATIENT ATTITUDE;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PUBLISHING;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
CARDIOVASCULAR DISEASES;
CHEMICALLY INDUCED;
HYPERCHOLESTEROLEMIA;
LITERATURE;
MUSCLE DISEASE;
PUBLICATION;
RISK ASSESSMENT;
CARDIOVASCULAR DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
MUSCULAR DISEASES;
PERIODICALS AS TOPIC;
RETRACTION OF PUBLICATION AS TOPIC;
REVIEW LITERATURE AS TOPIC;
RISK ASSESSMENT;
|
|
EID: 84905457714
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g5007 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (9)
|
